Salzberg, Marc <br/><br/>
Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients.  [electronic resource] 

 -  European journal of cancer (Oxford, England : 1990)  Oct 2006 
 - 2660-1 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0959-8049 
<br/><br/><label>Standard No.: </label>10.1016/j.ejca.2006.06.009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Transitional Cell--drug therapy<br/>Drug Administration Schedule<br/>Humans<br/>Middle Aged<br/>Neoplasm Proteins--metabolism<br/>Receptor, ErbB-2--metabolism<br/>Trastuzumab<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy